Mineral City
Mineral City AI offers a B2B SaaS platform that utilizes proprietary XR Vision technology for product authentication without opening packages. Their AI-powered software analyzes scans of shipments in real-time to confirm product presence, detect anomalies, and prevent counterfeiting and diversion, particularly in high-stakes industries like pharmaceuticals, medical devices, and luxury goods. The company aims to enhance supply chain integrity, ensure patient safety, and protect brand credibility by providing irrefutable, rapid, and bulk product verification, thereby creating a world where AI and advanced scanning technologies ensure safer products and more transparent supply chains.
Mineral City
Mineral City AI offers a B2B SaaS platform that utilizes proprietary XR Vision technology for product authentication without opening packages. Their AI-powered software analyzes scans of shipments in real-time to confirm product presence, detect anomalies, and prevent counterfeiting and diversion, particularly in high-stakes industries like pharmaceuticals, medical devices, and luxury goods. The company aims to enhance supply chain integrity, ensure patient safety, and protect brand credibility by providing irrefutable, rapid, and bulk product verification, thereby creating a world where AI and advanced scanning technologies ensure safer products and more transparent supply chains.
TL;DR
Product: XR Vision — X‑ray powered, AI‑enhanced enterprise SaaS for non‑destructive inspection and sealed‑product authentication
Primary markets: Pharmaceuticals, medical devices, nutraceuticals, fragrances, luxury/high‑value goods
Founded: 2022
Headquarters: Ponte Vedra, Florida
Recent funding signal: Series A announced Jul 1, 2025
Company Overview
Problem Domain
Supply‑chain integrity, product authentication, anti‑counterfeiting, quality verification for sealed high‑value and regulated goods.
Founded
2022
Industry
DeepTech
Tech Stack
Funding Track Record
Series A announced on Jul 1, 2025 (sources indicate multiple funding rounds; detailed amounts and investor names not published in provided evidence)